Literature DB >> 26012543

Coexistence of a T118M PMP22 missense mutation and chromosome 17 (17p11.2-p12) deletion.

Nivedita U Jerath1, John Kamholz1, Tiffany Grider1, Amy Harper2, Andrea Swenson1, Michael E Shy1.   

Abstract

INTRODUCTION: We describe a 6-year-old girl with a T118M PMP22 mutation and heterozygous deletion of PMP22 on chromosome 17 (17p11.2-p12) resulting in a severe sensorimotor polyneuropathy.
METHODS: This study is a case report in which the relevant mutations are described.
RESULTS: Foot pain, cavovarus feet, tibialis anterior atrophy, absent reflexes, and inability to walk were found when the patient was age 6 years. Nerve conduction studies showed evidence of a sensorimotor polyneuropathy and compressive mononeuropathies of bilateral median nerves at the wrist and ulnar nerves at the elbow. Genetic testing revealed deletion of a PMP22 allele and T118M PMP22 mutation in the remaining allele.
CONCLUSIONS: The severe sensorimotor polyneuropathy and hereditary neuropathy with liability to pressure palsies (HNPP) in this patient was likely a consequence of both decreased expression of PMP22 causing features consistent with HNPP and unopposed expression of the T118M mutant form of PMP22 that is relatively benign in the heterozygous state. The T118M mutant form of PMP22 can be disease-modifying in the appropriate circumstances.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  HNPP; PMP22; T118M mutation; loss of function mutation; neurogenetics

Mesh:

Substances:

Year:  2015        PMID: 26012543      PMCID: PMC4596757          DOI: 10.1002/mus.24713

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Charcot-Marie-Tooth 1A: heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotype.

Authors:  P Seeman; R Mazanec; T Marikova; B Rautenstrauss
Journal:  Ann N Y Acad Sci       Date:  1999-09-14       Impact factor: 5.691

2.  T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy.

Authors:  Michael E Shy; Mena T Scavina; Alisa Clark; Karen M Krajewski; Jun Li; John Kamholz; Edwin Kolodny; Kinga Szigeti; Richard A Fischer; Gulam Mustafa Saifi; Steven S Scherer; James R Lupski
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

3.  Variable phenotypes are associated with PMP22 missense mutations.

Authors:  M Russo; M Laurá; J M Polke; M B Davis; J Blake; S Brandner; R A C Hughes; H Houlden; D L H Bennett; M P T Lunn; M M Reilly
Journal:  Neuromuscul Disord       Date:  2010-12-30       Impact factor: 4.296

4.  Age associated axonal features in HNPP with 17p11.2 deletion in Japan.

Authors:  H Koike; M Hirayama; M Yamamoto; H Ito; N Hattori; F Umehara; K Arimura; S Ikeda; Y Ando; M Nakazato; R Kaji; K Hayasaka; M Nakagawa; S Sakoda; K Matsumura; O Onodera; M Baba; H Yasuda; T Saito; J Kira; K Nakashima; N Oka; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

5.  Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A.

Authors:  B B Roa; C A Garcia; L Pentao; J M Killian; B J Trask; U Suter; G J Snipes; R Ortiz-Lopez; E M Shooter; P I Patel; J R Lupski
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

6.  Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies.

Authors:  Jun Li; Karen Krajewski; Richard A Lewis; Michael E Shy
Journal:  Muscle Nerve       Date:  2004-02       Impact factor: 3.217

7.  Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth disease.

Authors:  Joshua Burns; Manoj Menezes; Richard S Finkel; Tim Estilow; Isabella Moroni; Emanuela Pagliano; Matilde Laurá; Francesco Muntoni; David N Herrmann; Kate Eichinger; Rosemary Shy; Davide Pareyson; Mary M Reilly; Michael E Shy
Journal:  J Peripher Nerv Syst       Date:  2013-06       Impact factor: 3.494

8.  Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland.

Authors:  Silvia Ulrich; Florian F Hildenbrand; Ursula Treder; Manuel Fischler; Stephan Keusch; Rudolf Speich; Margrit Fasnacht
Journal:  BMC Pulm Med       Date:  2013-08-05       Impact factor: 3.317

  8 in total
  1 in total

Review 1.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.